Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.55 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.49 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.48 |
| ▸ | HPGDS | O60760 | 2/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.46 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.46 |
| ▸ | NT5E | P21589 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23733840 | 0.94 | TAAR1 (0.57) | TAAR1DPP4ESR2ABCG2ABCC1 | |
| SCHEMBL23733871 | 0.94 | TAAR1 (0.62) | TAAR1DPP4ESR2ABCG2ABCC1 | |
| SCHEMBL28880094 | 0.94 | TAAR1 (0.57) | TAAR1DPP4ESR2ABCG2ABCC1 | |
| SCHEMBL23733839 | 0.94 | TAAR1 (0.57) | TAAR1DPP4ESR2ABCG2ABCC1 | |
| SCHEMBL27095780 | 0.94 | DPP4 (0.57) | TAAR1DPP4ABCG2ABCC1HPGDS | |
| SCHEMBL25788313 | 0.94 | DPP4 (0.57) | TAAR1DPP4ABCG2ABCC1HPGDS | |
| SCHEMBL23733874 | 0.89 | DPP4 (0.47) | TAAR1DPP4ABCG2 | |
| SCHEMBL23733782 | 0.89 | DPP4 (0.47) | TAAR1DPP4ABCG2 | |
| SCHEMBL23733793 | 0.89 | DPP4 (0.47) | TAAR1DPP4ABCG2 | |
| SCHEMBL23733862 | 0.89 | DPP4 (0.47) | TAAR1DPP4ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230099759-A1 | POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-03-30 | — | — | US | disclosed |
| WO-2021132733-A1 | POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230099759-A1 | POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | SLCO4C1, SLCO1A2, PORCN | TAAR1 2595/4885DPP4 3990/4885ESR2 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.